LUCD

$0.40+2.03%

Lucid Diagnostics Inc.

Market Cap

$81M

Live price × SEC shares (Aug 10, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

1.23

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

7.4

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	1,211		1,256	1,474
Cost of revenue			1,625	1,445
Research & development	1,272	1,723	1,206	1,192	5,393
Total operating expenses	12,970
Operating income	(11,759)	(14,011)	(12,114)	(12,801)	(50,685)
Interest expense	2.00		6.00	4.00
Pretax income	(10,397)	(16,266)	(13,909)	(11,687)	(52,259)
Income tax			0.00	0.00
Net income	(10,397)	(16,266)	(13,909)	(11,687)	(52,259)
EPS (basic) ($)	(0.10)		(0.17)	(0.08)	—
EPS (diluted) ($)	(0.10)
Weighted avg. shares (basic)	108,176		140,097	183,124
Weighted avg. shares (diluted)	108,176

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 12, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 20 more quarters, back to Sep 2020, with Tormere Pro.

Signals

purchases / sales, 90d

Short Volume

70%

W/W +12.8pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-05-20	2026-05-21	Matheis Dennis	Director	Purchase	245.0K	$1.00	$245K	1.03M	View
2025-08-20	2025-08-22	Matheis Dennis	Director	Purchase	100.0K	$1.02	$102K	665.4K	View
2025-05-22	2025-05-22	Matheis Dennis	Director	Purchase	33.2K	$1.32	$44K	350.0K	View
2025-05-21	2025-05-22	Matheis Dennis	Director	Purchase	129.7K	$1.32	$172K	316.8K	View
2025-05-20	2025-05-22	Matheis Dennis	Director	Purchase	187.1K	$1.29	$242K	187.1K	View

Reporting Insiders

Recent News

Mettler-Toledo (MTD) Surpasses Q3 Earnings and Revenue Estimates

Yahoo · 2026-11-05

Lucid Diagnostics Recognized as a GenomeWeb Best Place to Work for Second Consecutive Year

Yahoo · 2026-11-05

Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Yahoo · 2026-11-04

Lucid Diagnostics Announces Publication of Landmark 12,000-Patient Real-World EsoGuard® Study

Yahoo · 2026-11-03

PAVmed Unit Lucid Diagnostics Announces Publication Of Clinical Findings From Nonendoscopic Esophageal Precancer Testing Using The EsoGuard; Study Demonstrates Efficiency And Scalability Of EsoCheckCell Collection In Under Two Minutes

Benzinga · 2026-11-03

PAVmed to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 13, 2026

Yahoo · 2026-10-30

Lucid Diagnostics to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 12, 2026

Yahoo · 2026-10-29

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga · 2026-10-27

US Session Top Movers: CLRO and XXII Lead Stock Gainers and Losers

ChartMill · 2026-10-26

Unusual Volume in Small-Cap US Stocks: Mixed Session of Gains and Sharp Losses

ChartMill · 2026-10-26

US Session Top Percentage Movers: Gainers and Losers Among Small-Cap Stocks

ChartMill · 2026-10-26

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga · 2026-10-26

Lucid Diagnostics Begins Receiving Medicare Reimbursement for EsoGuard® and Closes $15 Million Financing

Yahoo Finance · 2026-10-22

Lucid Diagnostics Advances Multiple EsoGuard® and EsoCheck® Payment, Billing and Coding Pathways

Yahoo Finance · 2026-09-22

A new billing code was approved for a tool that collects esophageal cells. Medicare payment remains pending.

Stock Titan · 2026-09-22

Informational purposes only, not investment advice.

Date	Insider	Type	Shares	Value
2026-05-20	Matheis Dennis	P	245,000	$245,269.5
2025-08-20	Matheis Dennis	P	100,000	$101,840
2025-05-22	Matheis Dennis	P	33,218	$43,794.61
2025-05-21	Matheis Dennis	P	129,684	$171,520.06
2025-05-20	Matheis Dennis	P	187,098	$242,291.91

LUCD

Financial Statements

Signals

Factor Profile

Reporting Insiders

Recent News

Lucid Diagnostics Inc. (LUCD)

Factor Profile